{"log_id": 6551678909992610590, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 0.000446, "average": 0.988852, "min": 0.92606}, "location": {"width": 188, "top": 196, "height": 28, "left": 201}, "words": "诱导产生CYP3A4"}, {"probability": {"variance": 0.00017, "average": 0.995418, "min": 0.929783}, "location": {"width": 830, "top": 231, "height": 45, "left": 201}, "words": "已经有研究对2型糖尿病患者的人群药代动力学特点进行了分析。结果发现这些"}, {"probability": {"variance": 0.000122, "average": 0.996122, "min": 0.946949}, "location": {"width": 829, "top": 280, "height": 43, "left": 202}, "words": "患者服用的其他药物对西格列汀的药代动力学没有产生有临床意义的影响。这些"}, {"probability": {"variance": 2.2e-05, "average": 0.997802, "min": 0.975858}, "location": {"width": 807, "top": 329, "height": 43, "left": 202}, "words": "药物主要是指2型糖尿病患者经常服用的药物,包括降胆固醇药物(如他汀类"}, {"probability": {"variance": 1.1e-05, "average": 0.99827, "min": 0.982811}, "location": {"width": 828, "top": 377, "height": 42, "left": 206}, "words": "贝特类、依折麦布)、抗血小板药物(如氯吡格雷)、降压药(如血管紧张素转"}, {"probability": {"variance": 0.001886, "average": 0.989886, "min": 0.738941}, "location": {"width": 833, "top": 425, "height": 41, "left": 204}, "words": "换酶抑制剂、血管紧张素受体阻滞剂、β受体阻滞剂、钙离子通道阻滞剂、氢氯"}, {"probability": {"variance": 0.004768, "average": 0.983577, "min": 0.577118}, "location": {"width": 830, "top": 473, "height": 41, "left": 205}, "words": "噻嗪)、镇痛和非甾体抗炎药(如萘普生、双氯芬酸、塞来考昔)、抗抑郁药(如"}, {"probability": {"variance": 7.1e-05, "average": 0.995277, "min": 0.960388}, "location": {"width": 827, "top": 520, "height": 41, "left": 208}, "words": "丁氨苯丙酮、氟西汀、舍曲林)、抗组胺药(如西替利嗪)、质子泵抑制剂(如"}, {"probability": {"variance": 0.000129, "average": 0.994855, "min": 0.945768}, "location": {"width": 707, "top": 568, "height": 39, "left": 209}, "words": "奥美拉唑、兰索拉唑)以及治疗勃起功能障碍的药物(如西地那非)"}, {"probability": {"variance": 0.000775, "average": 0.989271, "min": 0.862779}, "location": {"width": 825, "top": 614, "height": 41, "left": 210}, "words": "当地高辛与西格列汀合用时,西格列汀药代动力学曲线的曲线下面积(AUC,11"}, {"probability": {"variance": 2.5e-05, "average": 0.997283, "min": 0.98315}, "location": {"width": 253, "top": 671, "height": 28, "left": 213}, "words": "%)和平均峰药浓度(C"}, {"probability": {"variance": 9.5e-05, "average": 0.995451, "min": 0.955519}, "location": {"width": 519, "top": 663, "height": 35, "left": 518}, "words": "18%)都有轻度增加。目前认为这种增加程度没有"}, {"probability": {"variance": 2e-06, "average": 0.998964, "min": 0.993578}, "location": {"width": 832, "top": 708, "height": 43, "left": 209}, "words": "临床意义。尽管如此,对于接受地高辛治疗的患者仍应适当监测。当患者同时服"}, {"probability": {"variance": 0.001301, "average": 0.990578, "min": 0.769332}, "location": {"width": 831, "top": 755, "height": 45, "left": 212}, "words": "用100mg西格列汀和600mg环孢霉素(一种强效的p-糖蛋白抑制剂)时,西格列"}, {"probability": {"variance": 0.002218, "average": 0.98894, "min": 0.699822}, "location": {"width": 830, "top": 803, "height": 41, "left": 211}, "words": "药代动力学曲线的AUC和Cmax分别增加了29%和68%左右。但上述西格列汀的"}, {"probability": {"variance": 1e-06, "average": 0.999388, "min": 0.995895}, "location": {"width": 410, "top": 854, "height": 39, "left": 212}, "words": "药代动力学变化被认为不具有临床意义"}, {"probability": {"variance": 0.00117, "average": 0.980295, "min": 0.904255}, "location": {"width": 146, "top": 951, "height": 29, "left": 217}, "words": "盐酸二甲双胍"}, {"probability": {"variance": 3e-05, "average": 0.996654, "min": 0.978219}, "location": {"width": 827, "top": 985, "height": 45, "left": 216}, "words": "格列本脲:一项以2型糖尿病患者为研究对象的试验研究了单次给药药物之间的"}, {"probability": {"variance": 3.6e-05, "average": 0.996836, "min": 0.966613}, "location": {"width": 820, "top": 1032, "height": 44, "left": 221}, "words": "相互作用。结果表明,二甲双胍和格列本脲联合治疗不会对二甲双胍的药代动力"}, {"probability": {"variance": 0.003132, "average": 0.984873, "min": 0.695575}, "location": {"width": 827, "top": 1080, "height": 43, "left": 217}, "words": "学或药效学造成任何影响。研究中还可以观察到格列本腺药代动力学曲线的AUC"}, {"probability": {"variance": 0.00083, "average": 0.988238, "min": 0.882511}, "location": {"width": 827, "top": 1126, "height": 44, "left": 219}, "words": "减少、Cmax降低,但没有固定的趋势。由于是单次给药药物试验,且格本脲的"}, {"probability": {"variance": 1.7e-05, "average": 0.998413, "min": 0.975882}, "location": {"width": 827, "top": 1175, "height": 42, "left": 220}, "words": "血药浓度与其药效学之间没有相关性,因此观察到的这种药物相互作用的临床意"}, {"probability": {"variance": 3.1e-05, "average": 0.995806, "min": 0.987871}, "location": {"width": 73, "top": 1234, "height": 29, "left": 223}, "words": "义不大"}, {"probability": {"variance": 0.0015, "average": 0.98765, "min": 0.772832}, "location": {"width": 830, "top": 1266, "height": 47, "left": 219}, "words": "呋塞米:一项以健康受试者为研究对象的临床试验研究了单次给药二甲双胍和呋"}, {"probability": {"variance": 0.00243, "average": 0.989703, "min": 0.703074}, "location": {"width": 827, "top": 1314, "height": 44, "left": 223}, "words": "塞米之间的相互作用。研究结果表明,联合治疗对两种药物各自的药效学参数都"}, {"probability": {"variance": 0.000302, "average": 0.992846, "min": 0.890918}, "location": {"width": 826, "top": 1361, "height": 45, "left": 224}, "words": "有影响。呋塞米使得二甲双胍的血Cmax值增加了22%,ACU值增加了15%,但肾"}, {"probability": {"variance": 0.000868, "average": 0.988808, "min": 0.851045}, "location": {"width": 827, "top": 1406, "height": 48, "left": 223}, "words": "脏清除率没有明显变化。而二甲双胍使呋塞米的Cmax值比单独用药时降低了"}, {"probability": {"variance": 0.000864, "average": 0.99151, "min": 0.812659}, "location": {"width": 825, "top": 1454, "height": 47, "left": 226}, "words": "31%,AUC值减少了12%,药物的终木半衰期减少了32%,但肾脏清除率没有明"}, {"probability": {"variance": 0.000875, "average": 0.992614, "min": 0.821722}, "location": {"width": 822, "top": 1501, "height": 47, "left": 228}, "words": "显变化。没有文献记录有关二甲双胍和呋塞米长期共同用药时二者之间的相互作"}, {"probability": {"variance": 0, "average": 0.997923, "min": 0.997923}, "location": {"width": 27, "top": 1565, "height": 27, "left": 227}, "words": "用"}], "language": 3}